DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Preclinical Imaging (In-VIVO) Market by Modality and by Reagent - Global Forecast to 2021" report to their offering.
The global preclinical imaging market is estimated to grow at a high CAGR of 6.2% during 2016-2021; and is expected to be valued at USD 910.4 million by 2021.
Market growth in the global preclinical imaging market is mainly driven by factors such technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches. In addition, emerging markets (such as China and India) are offering new growth opportunities for preclinical imaging market players.
Geographically, North America is estimated to command the largest share of the global preclinical imaging market in 2016, followed by Europe. The large market share of the North American region can be attributed to the robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems.
However, continued outsourcing of in-house preclinical studies to emerging countries by U.S.-based pharmaceutical and biotechnology companies and reduced R&D expenditure by the Canadian government to support research studies are negatively affecting the growth of the preclinical imaging market in this region.
- Aspect Imaging Ltd.
- Bruker Corporation
- Fujifilm Holdings Corporation
- Li-Cor Biosciences
- MR Solutions Ltd.
- Mediso Ltd.
- Milabs B.V.
- Miltenyi Biotec GmbH
- Perkinelmer, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Preclinical Imaging Market Overview
6 Industry Insights
7 Global Preclinical Imaging Market, By Modality
8 Global Preclinical Imaging Market, By Reagent
9 Preclinical Imaging Market, By Region
10 Competitive Landscape
11 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/449qp6/preclinical